+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Prognostic value of circulating tumor cells in metastatic breast cancer: a systemic review and meta-analysis



Prognostic value of circulating tumor cells in metastatic breast cancer: a systemic review and meta-analysis



Clinical and Translational Oncology 18(3): 322-330



Metastatic breast cancer (MBC) remains the main cause of cancer-related death, and the clinical significance and prognostic role of circulating tumor cells (CTCs) in metastatic breast cancer are still controversial. Here, we conducted a meta-analysis to clarify the correlation between CTCs and the clinicopathological features and prognosis of MBC. We performed a comprehensive search of Pubmed and the ISI Web of Science through December 2014. Only articles that focused on MBC patients and detected CTCs using the CellSearch system were included. The associations between CTCs and survival rate and clinicopathological parameters, including molecular pattern, metastatic region and treatment response, were evaluated. This meta-analysis included 24 studies (3701 MBC patients), 13 prospective studies and 11 retrospective studies. We found that CTCs were more frequently detected with HER2 + primary tumors (pooled RR = 0.73, 95 % CI = 0.63-0.84). Additionally, higher CTC numbers indicated a worse treatment response (RR = 0.56, 95 % CI = 0.40-0.79), poorer PFS (RR = 0.64, 95 % CI = 0.56-0.73) and poorer OS (RR = 0.69, 95 % CI = 0.64-0.75) in MBC patients. Based on these results, we propose that HER2 positivity could be a significant risk factor for the presence of CTCs. Additionally, CTCs have a significant prognostic value for MBC patients. Therefore, CTCs should be continually monitored to guide the treatment of MBC patients, especially those with HER2 + primary tumors.

(PDF emailed within 0-6 h: $19.90)

Accession: 058637681

Download citation: RISBibTeXText

PMID: 26260915

DOI: 10.1007/s12094-015-1372-1


Related references

Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review. Bmc Cancer 17(1): 725, 2018

The Prognostic Value of HER2-Positive Circulating Tumor Cells in Breast Cancer Patients: A Systematic Review and Meta-Analysis. Clinical Breast Cancer 17(5): 341-349, 2017

Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment. Breast Cancer Research 13(3): R67, 2012

Meta-analysis of the prognostic value of circulating tumor cells in breast cancer. Clinical Cancer Research 18(20): 5701-5710, 2013

Prognostic value of circulating tumor cells and disseminated tumor cells in patients with ovarian cancer: a systematic review and meta-analysis. Journal of Ovarian Research 8: 38, 2016

Prognostic role of circulating tumor cells and disseminated tumor cells in patients with prostate cancer: a systematic review and meta-analysis. Tumour Biology 35(6): 5551-5560, 2014

The significant prognostic value of circulating tumor cells in triple-negative breast cancer: a meta-analysis. Oncotarget 7(24): 37361-37369, 2016

The significant prognostic value of circulating tumor cells in colorectal cancer: A systematic review and meta-analysis. Current Problems in Cancer 42(1): 95-106, 2017

The prognostic role of circulating tumor cells (CTCs) detected by RT-PCR in breast cancer: a meta-analysis of published literature. Breast Cancer Research and Treatment 130(3): 809-816, 2012

Time-Dependent Prognostic Impact of Circulating Tumor Cells Detection in Non-Metastatic Breast Cancer: 70-Month Analysis of the REMAGUS02 Study. International Journal of Breast Cancer 2013: 130470, 2013

Circulating tumor cells as prognostic marker in metastatic breast cancer. Expert Review of Anticancer Therapy 10(2): 171-177, 2010

Prognostic value of circulating tumor cells in primary and metastatic breast cancer. Expert Review of Anticancer Therapy 12(2): 203-214, 2012

The role of circulating tumor cells in metastatic breast cancer: prognostic and predictive value. Molecular Biology Reports 2018, 2018

The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancer. Breast Cancer Research and Treatment 137(2): 503-510, 2013

Circulating Tumor Cells in Metastatic Breast Cancer: A Prognostic and Predictive Marker. Journal of Patient-Centered Research and Reviews 1(2): 85-92, 2015